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Abstract
Background: The loss of perfluorocarbon (PFC) vapour in the expired gases during partial liquid
ventilation should be minimized both to prevent perfluorocarbon vapour entering the atmosphere
and to re-use the recovered PFC liquid.
Using a substantially modified design of our previously described condenser, we aimed to
determine how much perfluorocarbon liquid could be recovered from gases containing PFC and
water vapour, at concentrations found during partial liquid ventilation, and to determine if the
amount recovered differed with background flow rate (at flow rates suitable for use in neonates).
Methods: The expiratory line of a standard ventilator circuit set-up was mimicked, with the
addition of two condensers. Perfluorocarbon (30 mL of FC-77) and water vapour, at
concentrations found during partial liquid ventilation, were passed through the circuit at a number
of flow rates and the percentage recovery of the liquids measured.
Results: From 14.2 mL (47%) to 27.3 mL (91%) of the infused 30 mL of FC-77 was recovered at
the flow rates studied. Significantly higher FC-77 recovery was obtained at lower flow rates
(ANOVA with Bonferroni's multiple comparison test, p < 0.0001). As a percentage of the
theoretical maximum recovery, 64 to 95% of the FC-77 was recovered. Statistically significantly less
FC-77 was recovered at 5 Lmin-1 (ANOVA with Bonferroni's multiple comparison test, p < 0.0001).
Amounts of perfluorocarbon vapour recovered were 47%, 50%, 81% and 91% at flow rates of 10,
5, 2 and 1 Lmin-1, respectively.
Conclusion:  Using two condensers in series 47% to 91% of perfluorocarbon liquid can be
recovered, from gases containing perfluorocarbon and water vapour, at concentrations found
during partial liquid ventilation.
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Background
Partial liquid ventilation involves filling the lungs to func-
tional residual capacity with a liquid, in which oxygen and
carbon dioxide are soluble, while continuing ventilation
with a conventional gas ventilator.
Perfluorocarbon (PFC) liquids seem to be physiologically
ideal for liquid ventilation, yet they have two major draw-
backs. The first is environmental and the second major
concern is cost. All PFCs are photochemically stable, have
a high global warming potential [1] and are contributors
to the greenhouse effect [2]. It would seem prudent, there-
fore, to limit the losses of PFC during partial liquid venti-
lation, both to prevent PFC vapour entering the
atmosphere and to re-use the recovered PFC liquid. As all
the lost PFC is in the exhaled gases, an opportunity exists
to recover the PFC.
We have previously shown that up to 74% of PFC can be
recovered from saturated vapour using a simple chilled
condenser [3]. However, a major problem with the exper-
imental set-up and condenser for that study was that it
condensed the PFC from gas that was fully saturated with
PFC vapour and not humidified; a situation that would
not be found during the clinical use of partial liquid ven-
tilation. During partial liquid ventilation the gas in the
expiration limb consists of a mixture of expired gases
(which are saturated with PFC vapour) and the bias flow.
As such, the gas in the expiration limb would not be satu-
rated with PFC vapour and during partial liquid ventila-
tion the amount of PFC recoverable with a simple chilled
condenser would be limited. The presence of water
vapour would also complicate the process because, at
temperatures at which significant PFC vapour condenses,
water freezes.
Using a substantially modified design of our previously
described condenser, we aimed to see how much PFC liq-
uid could be recovered from gases containing PFC and
water vapour, at concentrations found clinically during
partial liquid ventilation, and to determine if the amount
recovered differed with background flow rate (at flow
rates suitable for use in neonates).
Methods
The experimental apparatus is shown in Figure 1. The pur-
pose of the apparatus was to mimic the expiratory line of
a standard ventilator circuit set-up and provide a gas mix-
ture that mimicked the water and FC-77 concentrations
found in the expired gases during partial liquid ventila-
tion of an approximately 3.5 kg infant [4]. This was
achieved using a bias gas flow and evaporating FC-77 into
the flow at the replacement rate used during partial liquid
ventilation of an infant.
To produce the required gas mixture a humidifier
(MR600, Fisher & Paykel Healthcare, Auckland, New Zea-
land) was set to give a chamber outlet temperature of
39°C and an inspiratory line outlet temperature of 37°C,
as is commonly used in clinical practice. A self-filling
chamber (MR290, Fisher & Paykel Healthcare, Auckland,
New Zealand) and conventional heated inspiratory circuit
(Fisher & Paykel Healthcare, Auckland, New Zealand)
were used. A sponge (#00–005, Multigate Medical Prod-
ucts, Sydney, Australia) was placed in the outlet of the
humidifier chamber as an FC-77 evaporator. Air was
delivered to the chamber at flows of 1 Lmin-1, 2 Lmin-1, 5
Lmin-1 and 10 Lmin-1. For each test 30 mL of FC-77
(vapour pressure = 9.99 kPa at 37°C) [5,6] was infused,
using a syringe pump, onto the evaporator over a one
hour period. Measurements were performed in triplicate
for each flow rate.
The air, water vapour and FC-77 vapour from the chamber
passed through two series-connected condensers. The first
condenser was designed to remove water vapour from the
gas mixture, in order to prevent the formation of ice in the
second condenser. The first condenser consisted of two
coaxial tubes (modified from prototype ventilator circuits,
10 mm internal diameter, smooth bore, 1 m long, Fisher
& Paykel Healthcare, Auckland, New Zealand). The outer
coaxial tube was cooled to 1°C (2219 Thermostatic Circu-
lator, LKB, Bromma, Sweden) and the gas mixture passed
through the inner tube with a total condensing surface of
0.063 m2.
The second condenser was designed to remove PFC from
the gas mixture. It consisted of a 1 m long stainless steel
tube (13 mm internal diameter, 1 mm wall thickness)
with an outer jacket of 20 mm PVC tubing cooled to -
30°C (9102 Circulator, Polyscience, Niles, Illinois, USA)
Experimental apparatus Figure 1
Experimental apparatus. A = air inlet, H = humidifier, W 
= water, P = perfluorocarbon inlet, E = perfluorocarbon 
evaporator, I = heated inspiratory line, C1 = 1°C condenser, 
C2 = -30°C condenser, T1, T2 = traps.BioMedical Engineering OnLine 2006, 5:7 http://www.biomedical-engineering-online.com/content/5/1/7
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and the gas mixture passed through the inner tube with a
condensing surface of 0.041 m2.
At the conclusion of each experiment the condensers were
warmed to ~2°C to ensure any water ice had melted, the
volumes of water and FC-77 in each trap were measured
and the total volumes calculated. The percentage of theo-
retical maximum recovery was calculated (see below). The
humidifier chamber was visually inspected for the pres-
ence of any residual FC-77. The system was flushed with
dry air for at least 60 minutes between experiments.
At all flow rates studied the gas stream would be saturated
with water vapour which has a density of 44 mgL-1 at
37°C and 5.2 mgL-1 at 1°C [7]. Therefore a theoretical
maximum of 38.8 mg of water could be condensed for
each litre of air passing through the condensers. This cor-
responds to a maximum water recovery of 2.3 mL, 4.7 mL,
11.6 mL and 23.3 mL at 1 Lmin-1, 2 Lmin-1, 5 Lmin-1 and
10 Lmin-1 respectively.
The saturated vapour density of FC-77 is 1.6 gL-1 at 37°C,
0.28 gL-1 at 1°C and 0.04 gL-1 at -30°C [5]. In these exper-
iments the vapour was not saturated and the pre-con-
denser vapour density was calculated by dividing the
weight of FC-77 infused (53.4 g) by the total volume of air
passed during the experiment. Thus the FC-77 vapour
densities were 0.89 gL-1, 0.45 gL-1, 0.18 gL-1 and 0.09 gL-1
at 1 Lmin-1, 2 Lmin-1, 5 Lmin-1 and 10 Lmin-1 respectively.
The condensers cannot reduce the vapour density below
the saturation vapour density at the condenser tempera-
ture, dictating the maximum amount of FC-77 that can
theoretically be condensed. The maximum possible FC-77
recovery was 28.7 mL, 27.3 mL, 23.3 mL and 16.5 mL at
1 Lmin-1, 2 Lmin-1, 5 Lmin-1 and 10 Lmin-1 respectively.
Statistical comparisons were made using ANOVA with
Bonferroni's multiple comparison test.
Results
No unevaporated FC-77 remained in the humidifier
chamber at any flow rate. From 14.2 mL (47%) to 27.3
mL (91%) of the infused 30 mL of FC-77 was recovered at
the flow rates studied, and from 4 to 26 mL of water was
recovered (Figure 2). Significantly higher FC-77 recovery
was obtained at lower flow rates (p < 0.0001). Signifi-
cantly higher water recovery was obtained at higher flow
rates (p < 0.0001).
As a percentage of the theoretical maximum recovery,
mean recoveries were 64 to 95% for FC-77 and 88 to
140% for water (Figure 3). Statistically significantly less
FC-77 was recovered at 5 Lmin-1 (p < 0.0001) and signifi-
cantly higher water recovery was obtained at 1 Lmin-1 (p <
0.01).
Discussion
For economic and environmental reasons it is desirable to
minimise the loss of PFCs during partial and total liquid
ventilation. Some of the properties of PFCs that make
them ideal for liquid ventilation also make recovery and
re-use possible. FC-77 has a density of 1.78 gcm-3 and is
not miscible with water [5] and thus they can be easily
separated from each other. Being hydrophobic PFCs do
not support bacterial growth. No chemical decomposi-
Recovered Volumes Figure 2
Recovered Volumes. Volumes of FC-77 and water recovered at different flow rates (mean ± sem). For FC-77, all pairs 
except 5 and 10 Lmin-1 are significantly different (p < 0.05). For water, all pairs except 1 and 2 Lmin-1 are significantly different 
(p < 0.05).
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tion occurs at body temperature and biological materials
will not dissolve in PFCs. As such, the PFCs can easily be
washed and filtered for reuse in the same patient. All PFC
loss occurs through evaporation and the PFC vapour all
passes through the expiratory line of the ventilator circuit.
This provides an opportunity to condense the PFC vapour
from expired gases.
Perfluorooctyl bromide [8,9] loss rates of 2 to 6 ml/kg/h
and FC-77 [4] loss rates of around 7 ml/kg/hr have been
reported for partial liquid ventilation.
The amount of vapour passing into the exhalation line
during partial liquid ventilation depends primarily on the
surface area of the PFC-air interface and the temperature.
Hence, the concentration in the expiratory line depends
on the amount of PFC and the gas flow rate. The vapour
pressure (perfluorooctyl bromide (1.47 kPa at 37°C) [5]
and FC-77 (9.99 kPa at 37°C) [5,6]) and, hence, the
vapour density, of the PFC will impact on the condensa-
tion efficiency. Having a lower vapour pressure, per-
fluorooctyl bromide evaporates less than FC-77, but also
will more readily condense. The amount of perfluorooctyl
bromide recoverable will need to be tested in future exper-
iments.
Using a humidified circuit, we studied the recovery of FC-
77 with a loss rate of 30 ml/hr, corresponding to the loss
rate expected for an approximately 3.5 kg infant [4]. A pre-
vious study showed recoveries of up to 74% when exam-
ining the recovery of FC-77 from saturated, non
humidified, vapour – a situation which would not be
found in clinical partial or total liquid ventilation [3].
Two series-connected condensers were employed, the first
at 1°C to remove water (which would solidify in the sec-
ond condenser) and the second at -30°C to condense the
FC-77.
Water is readily condensed at 1°C and over 88% of the
theoretical maximum [7], was recovered at all flow rates
studied. The greater than theoretical recovery at 1 Lmin-1
may be attributed to the carry over of a few drops of par-
ticulate water, the humidifier over heating slightly at this
low flow rate, or inaccuracies in the flowmeter.
A small amount of water (up to 3 mL) was found in the
second (-30°C) condenser, particularly at higher flow
rates. This water forms ice in the second condenser and
may block the condenser. In research or clinical practice it
would be necessary to have two condensers which could
be used alternatively to allow any water ice to melt. Con-
denser switching would be automated based on an
increase in differential pressure across the condenser.
Additional safety 'blow-off' valves would also used to pre-
vent excessive circuit pressures in the event of condenser
blockage.
In absolute terms, 47% to 91% of the evaporated PFC was
recovered. Over 65% of the theoretical maximum amount
of PFC was recovered at all flow rates studied. At the com-
monly used flow rate of 10 Lmin-1, 86% of the theoretical
Recovery Percentages Figure 3
Recovery Percentages. Percentages of the theoretical maximum recovery for FC-77 and water at different flow rates (mean 
± sem). For FC-77, 1 and 2; 2 and 10 Lmin-1 are significantly different (p < 0.05). For water, 1 Lmin-1 is significantly different (p 
< 0.05) from all other rates.
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maximum was recovered. The drop in recovery at 5 and 10
Lmin-1 can be attributed to either reduced efficiency of the
second condenser at these high flow rates or a probable
change from laminar to turbulent flow. Various strategies
could be employed to improve the efficiency of the sec-
ond condenser at the higher flow rates: increasing the
length of the condenser would increase the surface area;
packing the condenser with stainless steel wool would
cause turbulence in the flow, as well as increasing the sur-
face area for condensation.
Further cooling of the second condenser would also
increase the recovery. Cooling to dry ice temperature (-
78°C) would increase the theoretical maximum recovery
of FC-77 to >99% of the infused volume at a flow rate of
10 Lmin-1, compared with a theoretical maximum recov-
ery of 55% of the infused volume with a condenser tem-
perature of -30°C [5]. -30°C was employed in the current
study as the lowest temperature obtainable with the appa-
ratus.
Using a complicated rebreathing system, Schhrader et al
obtained a 90% recovery rate for perfluorooctyl bromide
in animal studies utilizing partial liquid ventilation [10].
Specially designed heat and "moisture" exchangers fitted
to the endotracheal tube may be also used to minimize
PFC loss during partial liquid ventilation, with 60% more
perfluorooctyl bromide retained than without the
exchanger [11]. These methods, however, all require com-
plicated ventilator circuits and equipment or add dead
space that would be unacceptable in neonatal ventilation.
This study represents a substantial advancement in the
development of a perfluorocarbon vapour recovery cir-
cuit. We have been able to overcome the problems of
expired gases not fully saturated with PFC vapour and yet
fully saturated with water vapour. We have demonstrated
this at flow rates that are used in neonatal ventilation. We
have further refined the design of the expiratory circuit
with a small surface area, which would not significantly
alter conventional ventilator function, that achieves PFC
recovery similar to other methods. For the first time,
recovery of PFC from expired gases that are not saturated
with PFC, and saturated with water, have been demon-
strated. Further studies will be necessary to determine the
PFC recovery that can be achieved with flow rates and ven-
tilator circuits suitable for paediatric and adult ventila-
tion. Whilst recovery would be less at higher flow rates in
bigger patients some recovery would still be possible, and
some is better than none. Also the increase in size of the
patients would make modifications possible to improve
condensation.
Conclusion
Using two series connected condensers 47% to 91%, of
PFC liquid (FC-77) can be recovered from clinical relevant
gas mixtures without altering the function of the expira-
tory line of a ventilator circuit. Further development of the
system could allow re-use of the PFC recovered during
partial liquid ventilation; thus curtailing loss of PFC to
atmosphere and the potential high costs of partial liquid
ventilation.
List of abbreviations
PFC – perfluorocarbon
ANOVA – analysis of variance
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
KRD conceived the study, constructed the apparatus, car-
ried out the experiments, performed the statistical analysis
and drafted the manuscript. MWD conceived the study,
participated in its design and coordination, assisted in the
statistical analysis and revised the manuscript. JFF assisted
in data analysis and interpretation, and revised the manu-
script. All authors read and approved the final manu-
script.
Acknowledgements
This project was funded by a research grant from the Royal Brisbane and 
Women's Hospital Foundation.
References
1. Anonymous: 3M Material Safety Data Sheet FC-77 Fluorinert
Brand Electronic Liquid.  2003 [http://www.3m.com]. 09/03/2002,
Accessed July 21, 2003
2. AFEAS Program Office: Contribution of Greenhouse Gases to
Climate Forcing – Relative to CO2.  2003 [http://www.afeas.org].
Accessed July 21, 2003
3. Dunster KR, Davies MW: A novel expiratory circuit for recov-
ery of perfluorocarbon liquid during partial liquid ventila-
tion.  Intensive Care Med 2004, 30:514-516.
4. Davies MW, Stewart MJ, Chavasse R, Butt W: Partial liquid venti-
lation compared with conventional mechanical ventilation in
an experimental model of acute lung injury.  Crit Care Resus
2001, 3:81-85.
5. Anonymous: 3M Fluorinert Electronic Liquid FC-77 Product
Information.  2003 [http://www.3m.com]. May 2000, Accessed July
21, 2003
6. Shaffer TH, Greenspan JS, Wolfson MR: Liquid ventilation.  In New
therapies for neonatal respiratory failure Edited by: Boynton BR, Carlo
WA, Jobe AH. Cambridge: Cambridge University Press; 1994:282. 
7. Lemmon EW, McLinden MO, Friend DG: Thermophysical proper-
ties of fluid systems.  NIST Chemistry WebBook, NIST Standard Ref-
erence Database Number 69 2003 [http://webbook.nist.gov].
Gaithersburg MD: National Institute of Standards and Technology
20899 Accessed November 30, 2004
8. Doctor A, Al-Khadra E, Watson K, Thompson J, Arnold J: Perfluor-
ocarbon (PFC) vapor loss during high frequency ventilation:
effect of intrapulmonary PFC distribution and volume
[abstract].  Am J Respir Crit Care Med 2000, 161:A46.
9. Greenspan JS, Wolfson MR, Shaffer TH: Liquid ventilation: clinical
experiences.  Biomed Instrum Techno 1999, 33:253-259.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BioMedical Engineering OnLine 2006, 5:7 http://www.biomedical-engineering-online.com/content/5/1/7
Page 6 of 6
(page number not for citation purposes)
10. Schrader B, Westenskow D, Kofoed S, Durst K, Orr J, Flanagan C,
Mazzoni M, Hoffman J, Sekins M: A closed rebreathing system for
dose maintenance during partial liquid ventilation.  Biomed
Instrum Technol 1999, 33:373-382.
11. Nugent LJ, Mazzoni MC, Flaim S, Hoffman JK, Sekins KM: Dose
maintenance for partial liquid ventilation: passive heat-and-
moisture exchangers.  Biomed Instrum Technol 1999, 33:365-372.